FDA Approves Sorilux for Adolescent Plaque Psoriasis
The US Food and Drug Administration (FDA) has approved SORILUX (calcipotriene) Foam, 0.005% in adolescents.
The US Food and Drug Administration (FDA) has approved SORILUX (calcipotriene) Foam, 0.005% in adolescents.
Scott R. Miller, MD, FACS, examines how commodification threatens plastic surgery’s emphasis on judgment and craft—and makes the case for a low-volume, high-quality approach to patient care.